Background
==========

Emerging infectious diseases (EIDs) pose a serious threat to the health, stability, and persistence of human and wildlife populations \[[@B1]-[@B4]\]. Genetic and genomic tools have been incredibly useful for discovery of genes associated with host response and variation in resistance or susceptibility to a variety of pathogens \[[@B5]-[@B7]\]. The advent of genomic tools such as microarray analysis has offered new insights into host-pathogen systems. Additionally, their application to genomic response to host disease response allows rapid characterization of candidate genes for further research into control and eradication methods.

EIDs are a leading hypothesis for the global decline of amphibians and two pathogens in particular, *Batrachochytrium dendrobatidis*and Ranaviruses have been implicated in worldwide epizootics. Although studies are beginning to investigate possible mechanisms of resistance to these pathogens \[[@B8]\], in general, very little is known about the immune response of amphibians to EIDs. This is because most natural amphibian species are not used as laboratory models and we lack fundamental molecular tools to investigate disease pathology and host-pathogen interactions at the molecular level for all but a few species (e.g., *Ambystoma tigrinum spp., Xenopus spp*.).

Over the last 15 years, *Ranavirus*infections have been associated with marked increases in morbidity and mortality in fish, reptiles, and amphibians \[[@B9]\]. Ranaviruses are globally-distributed double-stranded, methylated DNA viruses of fish, amphibians and reptiles and are implicated in amphibian epizootics worldwide \[[@B9]-[@B11]\]. Both encapsulated and non-encapsulated forms can be infectious. The virus enters the cell via receptor mediated endocytosis or via fusion with the plasma membrane; and DNA and RNA synthesis occur in the nucleus, while protein synthesis occurs at morphologically specific assembly sites in the cytoplasm \[[@B9]\]. In North America, ranaviruses have been isolated from the majority of recent documented amphibian epizootics \[[@B12]\], including from tiger salamander (Ambystoma tigrinum) epizootics in Saskatchewan, Canada \[[@B13]\], Arizona \[[@B14]\], North Dakota, Utah, and Colorado, USA \[[@B15],[@B16]\]. The viral variant that infects tiger salamanders, ATV, is transmitted either via direct contact with an infected animal or immersion in water that contains virus and infected individuals exhibit systemic hemorrhaging, edema, ulceration, and necrosis of the integument and internal organs \[[@B13],[@B17],[@B18]\]. In cases where ATV infection leads to mortality, it usually occurs within 2--3 weeks of exposure, with animals displaying symptoms often between 8--10 days post-exposure. Thus, ATV can rapidly overwhelm the tiger salamander immune response. However, mortality is not always a pathological endpoint because virulence and resistance are known to vary among ATV strains and tiger salamander populations, respectively, as indicated by both laboratory experiments and field observations \[[@B19]\]. Research characterizing the tiger salamander genomic response to ATV is needed to better understand the pathology, virulence, and possible mechanisms of resistance to this emerging disease.

The tiger salamander species complex includes *A. mexicanum*(Mexican axolotl), a model organism with a growing genomic and informatics resource base \[[@B20]\]. The immune system of the Mexican axolotl has been extensively studied using several classical approaches. Relative to other vertebrate models, the axolotl immune response has been described as immunodeficient \[[@B21],[@B22]\]. There are several reasons for this characterization, including: production of only two immunoglobulin (Ig) classes, only one of which regulates the humoral response and neither of which is anamnestic \[[@B23],[@B24]\]; no response to soluble antigens \[[@B25]\]; poor mixed lymphocyte reactions \[[@B26],[@B27]\]; and lack of cellular cooperation during the humoral immune response as indicated by enhanced humoral immunity following thymectomy or X-ray irradiation \[[@B28],[@B29]\]. Weak immune responses are known for salamanders in general, and the Mexican axolotl and related tiger salamanders are especially susceptible to ATV infections with high observed mortality rates both in the laboratory and in the field. Indeed, an outbreak of ATV in 2003 at the Indiana Axolotl Colony significantly reduced adult stocks before the virus was contained. By way of comparison, adult *Xenopus*effectively clear close-related FV3 *Ranavirus*with an immune response that includes an early T-cell proliferative phase in the spleen \[[@B30]\].

To further investigate the axolotl immune response to ATV, we used an Affymetrix custom microarray to identify genes that were significantly, differentially expressed in the spleen. We then compared these genes to a list of genes associated with regeneration that were previously identified from *A. mexicanum*using the same microarray platform. We reasoned that such a comparison would allow us to filter gene expression responses of humoral cells induced generally in response to injury and stress from those expressed specifically in response to ATV infection. Also, this comparison would potentially identify gene expression signatures associated with cell proliferation in response to ATV, as we have previously identified many cell proliferation probe sets on the *Ambystoma*genechip that are differentially regulated during spinal cord regeneration \[[@B31]\]. The genes that we describe provide mechanistic insights and new tools to investigate salamander antiviral responses in the laboratory and in natural populations.

Methods
=======

Animal care and surgery protocols
---------------------------------

Inbred *A. mexicanum*eggs from a single full-sib mating were obtained from the Ambystoma Genetic Stock Center at the University of Kentucky. Each *A. mexicanum*egg and larva was reared in an individual container in aquifer water treated with ReptiSafe and changed weekly. Individuals were fed brine shrimp *ad libitum*for the first four weeks post-hatching and blackworms (Tubifex) *ad libitum*thereafter. Animals were reared in an environmental chamber on a 12:12 h light:dark cycle at 20°C. At 4.5 months of age, 12 individuals were injected with 100 μl of 10^6^p.f.u./ml of ATV isolated from the axolotl colony and suspended in cell culture medium. This amount of virus was determined to be the minimum lethal dose via injection in previous unpublished experiments (Storfer, unpublished data) and the strain utilized in the experiment was extracted from axolotls that had previously been infected and killed by the virus. Simultaneously, four uninfected (control) individuals were sacrificed in MS222 for spleen and lung removal. Spleens from all animals were flash frozen in liquid nitrogen. The same surgical procedure was performed on four infected individuals following 24, 72 and 144 hours of infection. Spleen tissue was utilized due to its previously noted importance in CD8+ T cell immune responses to Ranaviruses, particularly FV3, in frogs \[[@B30]\] Additionally, spleen is an important immune organ as antigens from the blood are processed in the spleen. Lung tissue was removed for viral quantification as it is an internal organ that can be utilized in early stage virus quantification (Stewart, unpublished data).

During the infection period behavioral observations were taken opportunistically. Total RNA was extracted from spleen with TRIzol (Invitrogen) according to the manufacturer\'s protocol. RNA isolations were further purified using RNeasy mini columns (Qiagen). The amount of RNA present in each isolate was determined via UV spectrophotometry, and RNA quality was inspected via a 2100 Agilent Bioanalyzer. Sixteen high quality isolates (four replicates at each of four sampling times: 0 (controls), 24, 72, and 144 hours post-infection) were used to make individual-specific pools of biotin labeled cRNA probes. Each of the 16 pools was then independently hybridized to an Amby_001 custom Affymetrix GeneChip (for a more detailed description of the microarray platform see \[[@B31]\] and \[[@B32]\]). The University of Kentucky Microarray Core Facility generated cRNA probes and performed hybridizations according to standard Affymetrix protocols.

Quality Control and Data Processing
-----------------------------------

All quality control and processing analyses were done in R \[[@B33]\]<http://www.r-project.org>. We used the Bioconductor package \"affy\" <http://www.bioconductor.org> to perform several quality control analyses at the individual probe level \[[@B34],[@B35]\]. These analyses included: (1) viewing images of the log(intensity) values of the probes on each GeneChip to check for spatial artifacts, (2) investigating measures of central tendency and dispersion by viewing box-plots and histograms of all the GeneChips, (3) viewing pair-wise M versus A plot matrices for replicate GeneChips, and (4) viewing an RNA degradation plot \[[@B35]\] that enables the visualization of the 3\' labeling bias associated with all GeneChips simultaneously. Upon conducting these probe level analyses, we background corrected, normalized, and summarized all sixteen GeneChips using the Robust Multi-array Average (RMA) algorithm \[[@B36]\]. Following this, we calculated correlation matrices for replicate GeneChips (four correlation matrices with four GeneChips per matrix; all *r*from replicate GeneChips \> 0.980) on the summarized probe-set level data. The strong correlations observed between replicate GeneChips suggests that we were able to obtain a high degree of repeatability within treatments.

Data Filtering
--------------

Microarrays may not accurately quantify the abundance of lowly expressed genes \[[@B37]\]. Calculating statistical tests for such genes adds to the multiple testing burden that is inherent to microarray studies. To address this issue, we filtered genes whose mean intensity across all 16 GeneChips was greater than the mean of the lowest quartiles (25^th^percentiles) across all GeneChips (*n*= 16, mean = 5.83, SD = 0.06; data presented on a log~2~scale). Upon imposing this filtering criterion, 3619 probe-sets were available for significance testing.

Identifying Differentially Expressed Genes
------------------------------------------

We used the Bioconductor package LIMMA \[[@B38],[@B39]\] to generate moderated *t*-statistics for all six of the possible pair-wise contrasts of the four sampling times investigated in our study. LIMMA employs an empirical Bayes methodology that effectively shrinks the sample variances towards a pooled estimate. This approach reduces the likelihood of obtaining large test statistics due to underestimation of the sample variances. The moderated *t*-statistics generated by LIMMA test the null hypothesis that the difference between the two groups being compared is zero (*i.e*., group 1 -- group 2 = 0). LIMMA also generates moderated *F*-statistics that test the null hypothesis that none of the contrasts within a family of contrasts are statistically significant. We corrected for multiple testing by applying the step-up algorithm \[[@B40]\] to the *P*-values of the moderated *F*-statistics associated with our six contrasts. Upon correcting for multiple testing, we identified 2322 genes (probe-sets) that were statistically significant. To prioritize amongst differentially expressed genes, we focused on probe-sets that exhibited two-fold or greater changes at any time-point relative to controls. Any gene that was non-significantly down-regulated but significantly up-regulated at one or more time points was considered up-regulated, and vice versa for classification of up- versus down-regulation. We also required that these probe sets have moderated *F*-statistics greater than or equal to the 50^th^percentile of the 2322 *F*-statistics from the statistically significant probe-sets (*F*≥ 12.68). We further limited our analysis to only those probe sets that exhibited significant sequence identity with a human reference sequence. We note that 263 probe-sets with no functional annotation were statistically significant, differentially expressed by ≥ two-fold, and had *F*-values ≥ 12.68.

Clustering
----------

Hybridization intensities were averaged within treatment groups (0, 24, 72, and 144 hrs post-infection) and log~2~ratios were calculated for each non-zero sampling time relative to 0 hours post-infection. Genesis v. 1.6.0 \[[@B41],[@B42]\] was used cluster these log~2~ratio data and to generate heat maps. Clustering was conducted using a Self Organizing Map (SOM) algorithm. Default conditions were used with the exception that the SOM was allowed to run for 263,000 iterations. The dimensions of the final SOM are 2~x~\*1~y~. These dimensions were determined by comparing output from several different combinations.

Enrichment Analyses
-------------------

Functional annotation of genes by gene ontology was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID, \[[@B43]\]). Functional annotation clustering was performed using the default settings with the exception of using the highest classification stringency.

Quantitative real-time PCR
--------------------------

We used quantitative real-time PCR (qPCR) to confirm the results of the microarrays. We estimated a fold change for 24 and 72 hr time points using the ΔΔct method of relative quantification \[[@B44]\], utilizing ribosomal protein L 19 as an endogenous control gene. The same total RNA that was used for microarray analysis was used to create cDNA for qPCR using the BioRad iScript cDNA synthesis kit, following manufacturer instruction. Primers for the qPCR were designed using Primer Express 2.0 (Applied Biosystems). Primers were designed to encompass the sequence of GeneChip probe sets (Additional file [1](#S1){ref-type="supplementary-material"}). qPCR was accomplished using SYBR Green chemistry.

To verify that exposed animals were infected and to quantify viral load and replication over time, we performed qPCR on lung tissue with TaqMan chemistry following the protocol detailed in \[[@B45]\]. ANOVA with a Tukey\'s HSD correction for all pairwise comparisons was performed to determine if viral loads were significantly different across time points.

Results
=======

Viral load and disease pathogenesis
-----------------------------------

Viral load for each animal was estimated using qPCR and then averaged for each time point (Fig [1](#F1){ref-type="fig"}). The significant increase in viral load across time points indicates that animals were infected and that viral replication was occurring. ANOVA with a Tukey\'s correction for multiple comparisons confirmed that viral load increased linearly between 24, 72, and 144 hours post-infection, and all time points were significantly different from all other time points (F~3,44~= 242.56; p ≤ 0.01).

![Log values of viral particles quantified with quantitative real-time PCR across all time points.](1471-2164-9-493-1){#F1}

No animals displayed any gross symptoms of ATV infection in terms of hemorrhaging, lesions or edema, either externally or on any internal organs upon euthanasia and subsequent surgery. Similarly, there were no notable changes in behavior observed during the period of infection. This is likely due to the relatively short infection period utilized in this experiment. As noted in the introduction, infected animals often take 8--10 days, or more, to become symptomatic upon infection.

Gene clustering and functional annotation
-----------------------------------------

We identified 263 probe sets with statistically significant differences in mRNA abundances between Day 0 and any other subsequent time point (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). We assume that statistically significant probe sets correspond to genes that were differentially regulated after ATV infection. Cluster analysis of the statistically significant genes identified two groups that exhibited similar changes in mRNA abundance. After ATV infection at Day 0, 158 putative genes showed a significant increase in mRNA abundance at subsequent time points (Figure [2](#F2){ref-type="fig"}), while 105 transcripts showed a significant decrease (Figure [3](#F3){ref-type="fig"}). Thus, more genes were up-regulated than down-regulated in response to ATV infection. Overall, DAVID categorized statistically significant genes among 44 different groups that correspond to different biological processes. Eight of these groups contained more genes than would be expected by chance sampling of genes from the microarray (geometric mean p-value \< 0.05); these groups were considered significantly enriched with candidate genes relative to other groups (Table [3](#T3){ref-type="table"}). Four of these significant groups contain gene ontologies related to immune response and pathogen response, including innate immunity, complement activation, lysosome function, and antigen processing and presentation. The most enriched functional group contains genes primarily related to immune function and defense responses. The remaining four functional groups contain gene ontologies related to ion binding, ion transport, vitamin metabolism, and response to an unfolded protein. Many genes that were classified in broader biological process categories that are not directly immunity-related are nonetheless associated with immunity in vertebrates \[e.g. \[[@B46]-[@B48]\]\].

###### 

Genes which were significantly up-regulated at any time point. Numbers indicate fold change at that time point.

  Gene ID                               Gene Name                                                                                             24 hr   72 hr   144 hr
  ------------------------------------- ----------------------------------------------------------------------------------------------------- ------- ------- --------
  immune response                                                                                                                                             
  SRV_03329_at                          INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 5                                           11.85   82.22   91.04
  SRV_01342_at                          INTERFERON REGULATORY FACTOR 1                                                                        1.94    12.71   12.79
  SRV_01343_a\_at                       INTERFERON REGULATORY FACTOR 1                                                                        2.10    16.07   15.63
  SRV_13637_a\_at                       INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3 (1--8 U)                                                   1.75    8.48    10.88
  SRV_01199_a\_at                       CLUSTERIN                                                                                             1.05    4.35    8.02
  SRV_00442_at                          SOLUTE CARRIER FAMILY 11 (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 1                   1.28    6.17    5.38
  SRV_01303_a\_at                       GUANYLATE BINDING PROTEIN 1, INTERFERON-INDUCIBLE, 67 KDA                                             1.10    2.35    2.49
  SRV_02828_at                          2\'-5\'-OLIGOADENYLATE SYNTHETASE 3, 100 KDA                                                          2.47    13.56   9.35
  SRV_02072_at                          CATHEPSIN S                                                                                           1.54    5.51    6.43
  SRV_02588_a\_at                       LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN                                               4.04    26.37   24.40
  SRV_02586_at                          LECTIN, GALACTOSIDE-BINDING, SOLUBLE, 3 BINDING PROTEIN                                               3.88    21.30   18.03
                                                                                                                                                              
  response to virus                                                                                                                                           
  SRV_03073_at                          INTERFERON-INDUCED PROTEIN 44                                                                         2.05    9.44    13.16
  SRV_01439_a\_at                       MYXOVIRUS (INFLUENZA VIRUS) RESISTANCE 1, INTERFERON-INDUCIBLE PROTEIN P78 (MOUSE)                    3.13    29.23   36.80
  SRV_01441_at                          MYXOVIRUS (INFLUENZA VIRUS) RESISTANCE 1, INTERFERON-INDUCIBLE PROTEIN P78 (MOUSE)                    3.26    28.24   35.84
  SRV_04604_s\_at                       INTERFERON INDUCED WITH HELICASE C DOMAIN 1                                                           6.81    27.34   24.15
  SRV_04604_at                          INTERFERON INDUCED WITH HELICASE C DOMAIN 1                                                           7.27    25.43   22.62
  SRV_04518_at                          RIBONUCLEASE L (2\',5\'-OLIGOISOADENYLATE SYNTHETASE-DEPENDENT)                                       3.30    7.38    8.66
                                                                                                                                                              
  cell defense response                                                                                                                                       
  SRV_00353_at                          NEUTROPHIL CYTOSOLIC FACTOR 2 (65 KDA, CHRONIC GRANULOMATOUS DISEASE, AUTOSOMAL 2)                    1.05    2.07    1.73
  SRV_00264_a\_at                       MYELOPEROXIDASE                                                                                       1.60    7.60    4.10
                                                                                                                                                              
  antigen processing and presentation                                                                                                                         
  SRV_05347_at                          PROTEASOME (PROSOME, MACROPAIN) SUBUNIT, BETA TYPE, 9 (LARGE MULTIFUNCTIONAL PEPTIDASE 2)             1.27    3.73    4.25
                                                                                                                                                              
  lysosome/endosome                                                                                                                                           
  SRV_02581_a\_at                       LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1                                                               1.23    2.26    2.06
  SRV_12596_at                          EH-DOMAIN CONTAINING 1                                                                                1.22    4.16    3.47
                                                                                                                                                              
  inflammatory response                                                                                                                                       
  SRV_10702_at                          CYTOCHROME B-245, BETA POLYPEPTIDE (CHRONIC GRANULOMATOUS DISEASE)                                    1.69    5.58    4.40
  SRV_00330_at                          CYTOCHROME B-245, BETA POLYPEPTIDE (CHRONIC GRANULOMATOUS DISEASE)                                    1.59    4.74    3.89
  SRV_01877_at                          CHEMOKINE (C-X-C MOTIF) RECEPTOR 4                                                                    1.29    5.70    8.08
  SRV_02292_at                          N-myc (and STAT) interactor                                                                           1.15    2.29    2.29
  SRV_00453_a\_at                       TRANSFORMING GROWTH FACTOR, BETA 1 (CAMURATI-ENGELMANN DISEASE)                                       1.12    2.19    2.18
  SRV_01617_a\_at                       PENTRAXIN-RELATED GENE, RAPIDLY INDUCED BY IL-1 BETA                                                  2.83    12.82   17.76
                                                                                                                                                              
  cell cycle                                                                                                                                                  
  SRV_02067_at                          POLO-LIKE KINASE 3 (DROSOPHILA)                                                                       0.93    3.82    6.18
  SRV_11882_s\_at                       RAS HOMOLOG GENE FAMILY, MEMBER B                                                                     1.18    2.33    2.40
  SRV_02051_at                          RAS HOMOLOG GENE FAMILY, MEMBER B                                                                     1.26    2.15    2.28
  SRV_02050_at                          RAS HOMOLOG GENE FAMILY, MEMBER B                                                                     1.23    2.51    2.55
  SRV_00154_at                          EXOSTOSES (MULTIPLE) 1                                                                                0.90    2.07    1.90
                                                                                                                                                              
  glycolysis                                                                                                                                                  
  SRV_01520_at                          pyruvate kinase, muscle                                                                               1.41    4.60    4.22
  SRV_01519_a\_at                       pyruvate kinase, muscle                                                                               1.56    5.94    5.48
  B_s\_at                               ALDOLASE A, FRUCTOSE-BISPHOSPHATE                                                                     1.22    3.14    2.96
                                                                                                                                                              
  transcription                                                                                                                                               
  SRV_01351_at                          JUN B PROTO-ONCOGENE                                                                                  1.76    7.82    7.54
  SRV_01336_a\_at                       INHIBITOR OF DNA BINDING 3, DOMINANT NEGATIVE HELIX-LOOP-HELIX PROTEIN                                1.56    3.14    3.57
  SRV_02310_at                          EUKARYOTIC TRANSLATION TERMINATION FACTOR 1                                                           0.95    2.70    2.45
  SRV_03646_at                          SPEN HOMOLOG, TRANSCRIPTIONAL REGULATOR (DROSOPHILA)                                                  1.15    2.22    2.30
  SRV_02571_at                          HAIRY AND ENHANCER OF SPLIT 1, (DROSOPHILA)                                                           1.23    4.52    6.10
                                                                                                                                                              
  complement                                                                                                                                                  
  SRV_00137_a\_at                       COMPLEMENT COMPONENT 3                                                                                1.80    9.79    13.66
  SRV_01145_a\_at                       COMPLEMENT FACTOR B                                                                                   3.46    18.33   20.05
                                                                                                                                                              
  apoptosis                                                                                                                                                   
  SRV_02399_a\_at                       MATRIX METALLOPEPTIDASE 9 (GELATINASE B, 92 KDA GELATINASE, 92 KDA TYPE IV COLLAGENASE)               2.19    6.79    8.78
  SRV_02516_at                          HEAT SHOCK 70 KDA PROTEIN 5 (GLUCOSE-REGULATED PROTEIN, 78 KDA)                                       2.70    10.28   7.60
  SRV_04970_a\_at                       CASPASE RECRUITMENT DOMAIN FAMILY, MEMBER 6                                                           1.35    4.78    4.80
  SRV_08154_a\_at                       HEAT SHOCK 70 KDA PROTEIN 9B (MORTALIN-2)                                                             1.18    3.45    2.71
  SRV_04300_a\_at                       CYTOCHROME C, SOMATIC                                                                                 1.30    2.80    2.64
  SRV_02132_at                          EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 EPSILON 1                                                  1.21    3.56    3.38
  SRV_01812_a\_at                       HEAT SHOCK PROTEIN 90 KDA BETA (GRP94), MEMBER 1                                                      1.31    3.53    3.26
  SRV_03753_at                          GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE, BETA                                                          1.39    7.34    8.89
  SRV_03023_a\_at                       GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE, GAMMA                                                         1.00    3.73    5.99
                                                                                                                                                              
  metabolic process                                                                                                                                           
  SRV_05147_a\_at                       SYNDECAN BINDING PROTEIN (SYNTENIN)                                                                   1.27    4.78    4.42
  SRV_00332_a\_at                       glucose-6-phosphate dehydrogenase                                                                     1.32    4.55    3.35
  SRV_00292_a\_at                       PHOSPHOMANNOMUTASE 2                                                                                  1.14    2.61    2.65
  SRV_01737_a\_at                       UDP-N-ACTEYLGLUCOSAMINE PYROPHOSPHORYLASE 1                                                           1.84    2.18    2.59
  SRV_05108_a\_at                       PHOSPHOSERINE AMINOTRANSFERASE 1                                                                      1.12    1.97    2.48
  C_s\_at                               ALDOLASE A, FRUCTOSE-BISPHOSPHATE                                                                     1.15    2.42    2.27
  A_s\_at                               ALDOLASE A, FRUCTOSE-BISPHOSPHATE                                                                     1.24    3.64    3.39
  SRV_00129_a\_at                       ALDOLASE B, FRUCTOSE-BISPHOSPHATE                                                                     1.26    2.30    2.13
  SRV_02002_at                          CARBOXYLESTERASE 1 (MONOCYTE/MACROPHAGE SERINE ESTERASE 1)                                            1.28    3.86    2.38
                                                                                                                                                              
  signal transduction                                                                                                                                         
  SRV_02657_at                          PRE-B-CELL COLONY ENHANCING FACTOR 1                                                                  1.61    7.61    7.01
  SRV_03054_at                          MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE                                                        2.17    8.20    6.82
  SRV_01818_at                          THIOREDOXIN                                                                                           1.19    3.29    3.51
  SRV_01313_a\_at                       GRANULIN                                                                                              1.45    3.72    3.40
  SRV_01462_at                          NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B-CELLS 2 (P49/P100)                       1.59    3.67    2.77
  SRV_03006_a\_at                       IQ MOTIF CONTAINING GTPASE ACTIVATING PROTEIN 2                                                       1.23    2.59    2.69
  SRV_01480_at                          PURINERGIC RECEPTOR P2Y, G-PROTEIN COUPLED, 2                                                         1.47    3.17    2.44
  SRV_02894_a\_at                       CAP, ADENYLATE CYCLASE-ASSOCIATED PROTEIN 1 (YEAST)                                                   1.10    2.09    1.76
  SRV_00844_a\_at                       CHLORIDE INTRACELLULAR CHANNEL 1                                                                      1.15    1.95    2.10
                                                                                                                                                              
  membrane                                                                                                                                                    
  SRV_03227_at                          NIDOGEN 2 (OSTEONIDOGEN)                                                                              1.42    3.69    4.29
  SRV_01179_a\_at                       CD63 ANTIGEN (MELANOMA 1 ANTIGEN)                                                                     1.34    3.82    3.97
  SRV_02687_s\_at                       MANNOSE-6-PHOSPHATE RECEPTOR BINDING PROTEIN 1                                                        1.30    4.82    3.55
  SRV_04888_a\_at                       UDP-GLCNAC:BETAGAL BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE 5                                         2.41    4.44    3.50
  SRV_04819_a\_at                       TRANSMEMBRANE PROTEIN 49                                                                              1.46    3.40    3.20
  SRV_04070_a\_at                       LEUCINE RICH REPEAT CONTAINING 59                                                                     1.22    2.48    2.78
  SRV_03407_at                          FER-1-LIKE 3, MYOFERLIN (C. ELEGANS)                                                                  1.22    2.67    3.81
  SRV_05439_at                          HYPOTHETICAL PROTEIN LOC441168                                                                        1.40    3.43    2.79
  SRV_02874_a\_at                       BRAIN ABUNDANT, MEMBRANE ATTACHED SIGNAL PROTEIN 1                                                    1.33    2.80    2.31
  SRV_04226_a\_at                       GTPASE, IMAP FAMILY MEMBER 5                                                                          1.13    2.05    2.02
                                                                                                                                                              
  transport                                                                                                                                                   
  SRV_00744_a\_at                       ADIPOSE DIFFERENTIATION-RELATED PROTEIN                                                               3.49    12.49   7.34
  SRV_00294_s\_at                       PROTECTIVE PROTEIN FOR BETA-GALACTOSIDASE (GALACTOSIALIDOSIS)                                         1.53    5.23    4.73
  SRV_02592_a\_at                       LYSYL OXIDASE-LIKE 1                                                                                  1.18    2.81    4.59
  SRV_03991_a\_at                       SOLUTE CARRIER FAMILY 15, MEMBER 3                                                                    1.36    5.33    3.88
  SRV_03562_at                          ERO1-LIKE (S. CEREVISIAE)                                                                             1.00    2.24    1.77
  SRV_04996_at                          SOLUTE CARRIER FAMILY 7 (CATIONIC AMINO ACID TRANSPORTER, Y+ SYSTEM), MEMBER 3                        1.07    1.75    2.11
  SRV_01134_at                          ATPASE, H+ TRANSPORTING, LYSOSOMAL 56/58 KDA, V1 SUBUNIT B2                                           1.04    2.17    1.59
  SRV_01220_at                          CYTOCHROME C OXIDASE SUBUNIT VIB POLYPEPTIDE 1 (UBIQUITOUS)                                           1.15    4.51    4.18
  SRV_02133_a\_at                       GOLGI SNAP RECEPTOR COMPLEX MEMBER 2                                                                  1.05    2.24    1.88
                                                                                                                                                              
  extracellular region                                                                                                                                        
  SRV_02948_a\_at                       fibulin 1                                                                                             0.93    1.65    2.24
  SRV_01275_at                          fibulin 1                                                                                             0.81    1.54    2.10
  SRV_02965_at                          TISSUE FACTOR PATHWAY INHIBITOR 2                                                                     3.56    3.04    2.56
  SRV_03142_at                          ELASTIN MICROFIBRIL INTERFACER 1                                                                      1.11    3.37    3.73
                                                                                                                                                              
  ion binding                                                                                                                                                 
  SRV_00713_a\_at                       TRANSCOBALAMIN I (VITAMIN B12 BINDING PROTEIN, R BINDER FAMILY)                                       2.55    23.02   12.98
  SRV_02456_at                          GASTRIC INTRINSIC FACTOR (VITAMIN B SYNTHESIS)                                                        3.36    20.67   11.63
  SRV_07722_at                          CHROMOSOME 17 OPEN READING FRAME 27                                                                   0.94    4.46    4.63
  SRV_05460_at                          tripartite motif-containing 39                                                                        1.58    3.81    4.07
  SRV_05065_at                          tripartite motif-containing 17                                                                        1.53    2.86    3.46
  SRV_00371_a\_at                       FRUCTOSE-1,6-BISPHOSPHATASE 1                                                                         2.40    5.01    3.14
  SRV_00741_a\_at                       ADENOSINE DEAMINASE, RNA-SPECIFIC                                                                     1.44    3.76    2.86
  SRV_00562_a\_at                       PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 (PROSTAGLANDIN G/H SYNTHASE AND CYCLOOXYGENASE)                 1.29    2.05    2.54
  SRV_05448_at                          ATPase, Ca++ transporting, cardiac muscle, slow twitch 2                                              0.87    2.16    2.13
  SRV_02724_at                          METHIONINE ADENOSYLTRANSFERASE II, ALPHA                                                              1.66    2.06    1.56
  SRV_00449_a\_at                       LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN 1                                              1.05    1.79    3.15
  SRV_00131_a\_at                       SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH (OSTEONECTIN)                                                 1.19    1.99    2.74
  SRV_04896_a\_at                       TRANSKETOLASE (WERNICKE-KORSAKOFF SYNDROME)                                                           1.44    4.02    2.52
  SRV_02047_at                          ANNEXIN A2                                                                                            1.29    2.15    2.45
  SRV_01345_at                          INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3                                                          1.19    2.80    2.35
  SRV_12418_at                          MYOSIN, LIGHT POLYPEPTIDE 9, REGULATORY                                                               1.01    1.99    2.20
  SRV_01649_at                          RETICULOCALBIN 1, EF-HAND CALCIUM BINDING DOMAIN                                                      1.16    3.01    2.68
                                                                                                                                                              
  Protein binding/transport                                                                                                                                   
  SRV_03206_at                          V-SET AND IMMUNOGLOBULIN DOMAIN CONTAINING 4                                                          1.90    13.14   9.17
  SRV_00797_a\_at                       SERPIN PEPTIDASE INHIBITOR, CLADE H (HEAT SHOCK PROTEIN 47), MEMBER 1, (COLLAGEN BINDING PROTEIN 1)   1.77    4.67    4.79
  SRV_04964_a\_at                       TUBULIN, BETA 6                                                                                       1.06    2.53    2.55
  SRV_03477_a\_at                       TRANSMEMBRANE PROTEIN 4                                                                               1.59    2.22    2.39
  SRV_02085_at                          FK506 BINDING PROTEIN 1B, 12.6 KDA                                                                    1.29    1.71    2.18
  SRV_02652_a\_at                       PROTEIN DISULFIDE ISOMERASE FAMILY A, MEMBER 6                                                        1.28    2.16    1.99
  SRV_02814_at                          DNAJ (HSP40) HOMOLOG, SUBFAMILY B, MEMBER 1                                                           2.35    4.29    1.73
  SRV_03255_a\_at                       AHA1, ACTIVATOR OF HEAT SHOCK 90 KDA PROTEIN ATPASE HOMOLOG 1 (YEAST)                                 1.07    2.14    1.53
  SRV_05534_at                          HYPOTHETICAL PROTEIN MGC16212                                                                         1.74    4.05    3.73
  SRV_00840_a\_at                       COLD INDUCIBLE RNA BINDING PROTEIN                                                                    1.03    2.46    3.20
  SRV_01147_a\_at                       BIGLYCAN                                                                                              0.99    2.01    2.90
  SRV_05461_x\_at                       tripartite motif-containing 39                                                                        1.32    2.53    2.76
  SRV_02070_a\_at                       CYSTEINE AND GLYCINE-RICH PROTEIN 1                                                                   1.27    2.22    2.46
  SRV_00257_at                          KERATIN 18                                                                                            1.12    1.93    2.44
  SRV_04005_at                          KDEL (LYS-ASP-GLU-LEU) ENDOPLASMIC RETICULUM PROTEIN RETENTION RECEPTOR 3                             0.90    2.07    2.06
  SRV_02647_a\_at                       ARP2 ACTIN-RELATED PROTEIN 2 HOMOLOG (YEAST)                                                          1.23    2.33    1.93
  SRV_01234_a\_at                       CATENIN (CADHERIN-ASSOCIATED PROTEIN), ALPHA 1, 102 KDA                                               0.98    1.43    2.05
  SRV_01504_a\_at                       PHOSPHOGLUCONATE DEHYDROGENASE                                                                        1.19    2.20    1.50
  SRV_05174_a\_at                       THREE PRIME REPAIR EXONUCLEASE 2                                                                      1.57    5.55    5.02
                                                                                                                                                              
  protein modification                                                                                                                                        
  SRV_04305_a\_at                       GLYCINE N-METHYLTRANSFERASE                                                                           1.24    1.84    3.49
  SRV_01832_a\_at                       UBIQUITIN-CONJUGATING ENZYME E2L 3                                                                    1.04    2.09    1.99
  SRV_00309_at                          TRANSGLUTAMINASE 1 (K POLYPEPTIDE EPIDERMAL TYPE I, PROTEIN-GLUTAMINE-GAMMA-GLUTAMYLTRANSFERASE)      3.22    16.60   14.36
  SRV_02093_a\_at                       HEAT SHOCK 70 KDA PROTEIN 9B (MORTALIN-2)                                                             1.35    3.91    2.79
  SRV_02989_at                          HEAT SHOCK 70 KDA PROTEIN 8                                                                           2.28    6.93    2.73
  SRV_01225_at                          CRYSTALLIN, ALPHA B                                                                                   1.27    3.35    2.38
  SRV_05456_a\_at                       UBIQUITIN SPECIFIC PEPTIDASE 2                                                                        1.27    2.56    2.00
  SRV_05457_a\_at                       UBIQUITIN SPECIFIC PEPTIDASE 2                                                                        1.26    2.28    1.89
  SRV_11417_a\_at                       MATRIX METALLOPEPTIDASE 1 (INTERSTITIAL COLLAGENASE)                                                  5.26    13.96   3.65
  SRV_04306_at                          GLYCINE N-METHYLTRANSFERASE                                                                           1.03    2.15    4.66
  SRV_00327_a\_at                       CATHEPSIN K (PYCNODYSOSTOSIS)                                                                         1.37    3.23    3.94
                                                                                                                                                              
  cellular process                                                                                                                                            
  SRV_11663_a\_at                       TIMP METALLOPEPTIDASE INHIBITOR 1                                                                     1.96    24.74   23.31
  SRV_04387_at                          RETINOIC ACID RECEPTOR RESPONDER (TAZAROTENE INDUCED) 1                                               1.64    6.63    9.22
  SRV_03285_at                          RELATED RAS VIRAL (R-RAS) ONCOGENE HOMOLOG 2                                                          1.76    5.07    4.97
  SRV_04911_at                          SIMILAR TO THIOREDOXIN DOMAIN-CONTAINING 2                                                            1.34    3.15    3.20
  SRV_01534_at                          PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, ALPHA ISOFORM                                               1.15    2.04    2.18
  SRV_04858_at                          POLY (ADP-RIBOSE) POLYMERASE FAMILY, MEMBER 9                                                         0.97    2.36    2.15
  SRV_03421_a\_at                       LR8 PROTEIN                                                                                           1.31    1.95    2.02
  SRV_11406_at                          V-YES-1 YAMAGUCHI SARCOMA VIRAL RELATED ONCOGENE HOMOLOG                                              1.37    2.46    2.12
                                                                                                                                                              
  other                                                                                                                                                       
  SRV_03887_at                          DYNEIN, CYTOPLASMIC 1, LIGHT INTERMEDIATE CHAIN 1                                                     1.31    2.42    2.20
  SRV_01920_at                          poly (ADP-ribose) glycohydrolase                                                                      1.31    1.95    2.23
  SRV_00155_a\_at                       COAGULATION FACTOR XIII, A1 POLYPEPTIDE                                                               1.20    2.46    2.35
  SRV_01367_a\_at                       KERATIN 8                                                                                             1.19    2.90    3.29
  SRV_00775_at                          ARGINASE, TYPE II                                                                                     1.44    4.08    6.06
  SRV_11767_a\_at                       INTERFERON INDUCED TRANSMEMBRANE PROTEIN 5                                                            1.17    2.74    4.24
  SRV_07726_a\_at                       MACROPHAGE EXPRESSED GENE 1                                                                           1.69    4.25    3.18
  SRV_01302_at                          GUANYLATE BINDING PROTEIN 4                                                                           1.07    2.39    2.64
  SRV_02761_at                          ARGININE-RICH, MUTATED IN EARLY STAGE TUMORS                                                          1.10    2.17    1.99
  SRV_03758_a\_at                       ARRESTIN DOMAIN CONTAINING 2                                                                          0.90    5.48    8.72

###### 

Genes which were significantly down-regulated at any time point. Numbers indicate fold change at that time point.

  ID                                          NAME                                                                               24 hr   72 hr   144 hr
  ------------------------------------------- ---------------------------------------------------------------------------------- ------- ------- --------
  transcription                                                                                                                                  
  SRV_04230_at                                CHROMOSOME X OPEN READING FRAME 15                                                 0.73    0.44    0.50
  SRV_01344_a\_at                             INTERFERON REGULATORY FACTOR 2                                                     1.02    0.47    0.50
  SRV_01768_a\_at                             TAF9 RNA POLYMERASE II, TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR, 32 KDA   0.84    0.44    0.50
  SRV_03843_a\_at                             MEDIATOR OF RNA POLYMERASE II TRANSCRIPTION, SUBUNIT 31 HOMOLOG (YEAST)            0.95    0.50    0.45
  SRV_01892_at                                ZINC FINGER PROTEIN 282                                                            0.98    0.39    0.42
                                                                                                                                                 
  translation                                                                                                                                    
  SRV_03800_a\_at                             MITOCHONDRIAL RIBOSOMAL PROTEIN S7                                                 1.13    0.50    0.54
  SRV_03598_at                                MITOCHONDRIAL RIBOSOMAL PROTEIN L19                                                0.73    0.49    0.53
  SRV_04607_at                                PEPTIDE DEFORMYLASE-LIKE PROTEIN                                                   1.01    0.46    0.50
  SRV_04925_a\_at                             HYPOTHETICAL PROTEIN MGC11102                                                      1.01    0.43    0.48
  SRV_01958_at                                EUKARYOTIC TRANSLATION INITIATION FACTOR 4E BINDING PROTEIN 3                      1.05    0.32    0.31
                                                                                                                                                 
  Natural Killer cell mediated cytotoxicity                                                                                                      
  AE_at                                       TUBULIN, BETA 2C                                                                   0.88    0.52    0.49
                                                                                                                                                 
  Apoptosis                                                                                                                                      
  SRV_11815_at                                CASP2 AND RIPK1 DOMAIN CONTAINING ADAPTOR WITH DEATH DOMAIN                        0.70    0.45    0.52
  SRV_01489_at                                PRKC, APOPTOSIS, WT1, REGULATOR                                                    0.88    0.43    0.44
                                                                                                                                                 
  ion binding/transport                                                                                                                          
  SRV_03020_at                                TRAF-TYPE ZINC FINGER DOMAIN CONTAINING 1                                          0.85    0.49    0.53
  SRV_01742_at                                SPECTRIN, ALPHA, NON-ERYTHROCYTIC 1 (ALPHA-FODRIN)                                 0.82    0.46    0.52
  SRV_02131_a\_at                             PEPTIDASE (MITOCHONDRIAL PROCESSING) BETA                                          0.80    0.48    0.51
  SRV_02733_at                                MITOCHONDRIAL INTERMEDIATE PEPTIDASE                                               0.59    0.39    0.40
  SRV_04112_at                                HYPOTHETICAL PROTEIN FLJ20699                                                      0.93    0.42    0.39
  SRV_00559_a\_at                             PRIMASE, POLYPEPTIDE 1, 49 KDA                                                     0.79    0.42    0.39
  SRV_03126_at                                RING FINGER PROTEIN 113A                                                           0.95    0.39    0.39
  SRV_03759_at                                ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F0 COMPLEX, SUBUNIT S (FACTOR B)      0.91    0.30    0.25
  SRV_01177_a\_at                             ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1                                   1.19    0.52    0.49
  SRV_04638_a\_at                             MEMBRANE-ASSOCIATED RING FINGER (C3HC4) 7                                          0.78    0.44    0.47
  SRV_03403_at                                MAKORIN, RING FINGER PROTEIN, 1                                                    1.02    0.55    0.48
  SRV_02137_at                                GUANINE DEAMINASE                                                                  0.93    0.36    0.36
  SRV_12156_at                                TUMOR PROTEIN D52                                                                  0.93    0.58    0.45
  SRV_02173_at                                CHONDROITIN SULFATE PROTEOGLYCAN 3 (NEUROCAN)                                      1.38    0.57    0.20
                                                                                                                                                 
  metabolic process                                                                                                                              
  SRV_02346_a\_at                             GLUTATHIONE S-TRANSFERASE OMEGA 1                                                  1.04    0.54    0.47
  SRV_04215_at                                PHOSPHOGLUCOMUTASE 2                                                               1.08    0.57    0.46
  SRV_04397_at                                NITRILASE FAMILY, MEMBER 2                                                         0.86    0.49    0.46
  SRV_03369_at                                NON-METASTATIC CELLS 7, PROTEIN EXPRESSED IN (NUCLEOSIDE-DIPHOSPHATE KINASE)       1.00    0.55    0.43
  SRV_00123_at                                AMINOLEVULINATE, DELTA-, DEHYDRATASE                                               0.71    0.49    0.31
  SRV_00160_s\_at                             FUMARYLACETOACETATE HYDROLASE (FUMARYLACETOACETASE)                                0.83    0.61    0.49
  SRV_00135_at                                ASPARTOACYLASE (CANAVAN DISEASE)                                                   0.92    0.30    0.22
  SRV_01499_at                                6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 1                              0.88    0.65    0.47
  SRV_11745_at                                ACYL-COENZYME A OXIDASE 3, PRISTANOYL                                              0.87    0.51    0.47
  SRV_03094_at                                LIPOIC ACID SYNTHETASE                                                             0.83    0.47    0.47
  SRV_05217_a\_at                             SERINE DEHYDRATASE-LIKE                                                            1.03    0.52    0.33
                                                                                                                                                 
  transport                                                                                                                                      
  SRV_03906_at                                HEMATOPOIETIC STEM/PROGENITOR CELLS 176                                            0.81    0.49    0.58
  SRV_04743_a\_at                             HYPOTHETICAL PROTEIN FLJ22028                                                      0.98    0.54    0.50
  SRV_02065_a\_at                             ADAPTOR-RELATED PROTEIN COMPLEX 2, MU 1 SUBUNIT                                    0.90    0.59    0.48
  SRV_03218_a\_at                             GABA(A) RECEPTOR-ASSOCIATED PROTEIN-LIKE 2                                         0.93    0.28    0.37
  SRV_05300_a\_at                             SFT2 DOMAIN CONTAINING 2                                                           0.91    0.31    0.29
  SRV_05537_a\_at                             TRAFFICKING PROTEIN PARTICLE COMPLEX 6B                                            0.95    0.49    0.34
  SRV_02033_a\_at                             SELENIUM BINDING PROTEIN 1                                                         1.05    0.58    0.45
                                                                                                                                                 
  protein binding/modification                                                                                                                   
  SRV_04235_at                                hypothetical protein FLJ11280                                                      0.68    0.44    0.56
  SRV_02678_a\_at                             M-PHASE PHOSPHOPROTEIN 6                                                           0.84    0.45    0.51
  SRV_02198_a\_at                             GLUTAMYL-PROLYL-TRNA SYNTHETASE                                                    0.94    0.52    0.48
  SRV_01481_at                                PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 1                                         1.05    0.56    0.49
  SRV_01495_at                                PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2                                           1.04    0.41    0.31
  SRV_04077_a\_at                             UBIQUITIN-CONJUGATING ENZYME E2R 2                                                 0.78    0.51    0.47
  SRV_04977_s\_at                             CNDP DIPEPTIDASE 2 (METALLOPEPTIDASE M20 FAMILY)                                   1.27    0.49    0.22
  SRV_04977_at                                CNDP DIPEPTIDASE 2 (METALLOPEPTIDASE M20 FAMILY)                                   1.20    0.46    0.22
  SRV_01825_at                                UBIQUITIN-CONJUGATING ENZYME E2B (RAD6 HOMOLOG)                                    0.90    0.47    0.51
                                                                                                                                                 
  RNA binding/processing                                                                                                                         
  SRV_03823_at                                RNA BINDING MOTIF PROTEIN, X-LINKED 2                                              0.80    0.47    0.54
  SRV_03721_at                                SYF2 HOMOLOG, RNA SPLICING FACTOR (S. CEREVISIAE)                                  0.96    0.46    0.49
  SRV_03417_at                                MITOCHONDRIAL RIBOSOMAL PROTEIN S28                                                0.86    0.51    0.47
  SRV_03836_at                                EXOSOME COMPONENT 1                                                                1.03    0.46    0.46
                                                                                                                                                 
  cell cycle/cell division                                                                                                                       
  SRV_05218_a\_at                             COILED-COIL DOMAIN CONTAINING 5 (SPINDLE ASSOCIATED)                               0.68    0.36    0.46
  SRV_03244_a\_at                             FREQUENTLY REARRANGED IN ADVANCED T-CELL LYMPHOMAS 2                               0.89    0.38    0.46
  SRV_05024_at                                ZW10 INTERACTOR                                                                    0.96    0.41    0.44
  SRV_00804_at                                CDC6 CELL DIVISION CYCLE 6 HOMOLOG (S. CEREVISIAE)                                 0.70    0.50    0.42
  SRV_03256_at                                TPX2, MICROTUBULE-ASSOCIATED, HOMOLOG (XENOPUS LAEVIS)                             0.91    0.41    0.51
  SRV_04156_at                                CELL DIVISION CYCLE ASSOCIATED 8                                                   0.71    0.43    0.50
  SRV_03593_at                                DISCS, LARGE HOMOLOG 7 (DROSOPHILA)                                                0.66    0.39    0.49
  SRV_14350_at                                NIMA (NEVER IN MITOSIS GENE A)-RELATED KINASE 3                                    0.96    0.42    0.30
  SRV_02556_at                                SMC4 STRUCTURAL MAINTENANCE OF CHROMOSOMES 4-LIKE 1 (YEAST)                        0.69    0.43    0.47
  SRV_03257_at                                TPX2, MICROTUBULE-ASSOCIATED, HOMOLOG (XENOPUS LAEVIS)                             0.79    0.35    0.45
  SRV_02235_at                                KINESIN FAMILY MEMBER 11                                                           0.53    0.31    0.44
  SRV_01290_at                                FERRITIN, HEAVY POLYPEPTIDE 1                                                      1.00    0.54    0.42
  SRV_02151_a\_at                             CENTRIN, EF-HAND PROTEIN, 2                                                        0.65    0.39    0.39
  SRV_04253_a\_at                             NUCLEOLAR AND SPINDLE ASSOCIATED PROTEIN 1                                         0.62    0.28    0.37
  SRV_05141_at                                CYCLIN-DEPENDENT KINASE INHIBITOR 2C (P18, INHIBITS CDK4)                          0.85    0.57    0.37
  SRV_00033_copy4_at                          T-cell acute lymphocytic leukemia 1                                                1.02    0.47    0.36
  SRV_00033_at                                T-cell acute lymphocytic leukemia 1                                                0.97    0.44    0.35
  SRV_00033_copy2_at                          T-cell acute lymphocytic leukemia 1                                                0.96    0.46    0.34
  SRV_00033_copy1_at                          T-cell acute lymphocytic leukemia 1                                                0.96    0.44    0.33
  SRV_00033_copy3_at                          T-cell acute lymphocytic leukemia 1                                                0.94    0.44    0.33
                                                                                                                                                 
  membrane                                                                                                                                       
  SRV_04260_at                                CHROMOSOME 9 OPEN READING FRAME 46                                                 1.05    0.56    0.47
  SRV_04763_at                                CHROMOSOME 10 OPEN READING FRAME 57                                                1.24    0.46    0.42
  SRV_04650_a\_at                             TRANSMEMBRANE 6 SUPERFAMILY MEMBER 1                                               1.00    0.47    0.32
  SRV_05571_a\_at                             OXIDATION RESISTANCE 1                                                             0.77    0.37    0.42
  SRV_03611_a\_at                             TRANSLOCASE OF OUTER MITOCHONDRIAL MEMBRANE 70 HOMOLOG A (YEAST)                   0.97    0.55    0.48
                                                                                                                                                 
  kinase activity                                                                                                                                
  SRV_05333_at                                RIO kinase 3 (yeast)                                                               1.06    0.47    0.52
  SRV_05450_a\_at                             INTEGRIN BETA 1 BINDING PROTEIN 3                                                  0.87    0.53    0.46
  SRV_01863_at                                VACCINIA RELATED KINASE 1                                                          0.61    0.39    0.51
                                                                                                                                                 
  pinocytosis/endocytosis                                                                                                                        
  SRV_00866_at                                DISABLED HOMOLOG 2, MITOGEN-RESPONSIVE PHOSPHOPROTEIN (DROSOPHILA)                 0.84    0.49    0.43
                                                                                                                                                 
  DNA damage                                                                                                                                     
  SRV_04199_at                                NEI ENDONUCLEASE VIII-LIKE 3 (E. COLI)                                             0.75    0.41    0.37
  SRV_02222_at                                HUS1 CHECKPOINT HOMOLOG (S. POMBE)                                                 0.72    0.45    0.57
                                                                                                                                                 
  muscle development/contraction                                                                                                                 
  SRV_01033_a\_at                             INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1                                       1.18    0.38    0.53
  SRV_05143_a\_at                             MYOSIN, LIGHT POLYPEPTIDE 1, ALKALI; SKELETAL, FAST                                0.79    0.50    0.49
  SRV_00058_s\_at                             tropomyosin                                                                        0.89    0.53    0.48
                                                                                                                                                 
  other                                                                                                                                          
  SRV_01932_a\_at                             FICOLIN (COLLAGEN/FIBRINOGEN DOMAIN CONTAINING) 3 (HAKATA ANTIGEN)                 1.03    0.58    0.46
  SRV_05356_s\_at                             FAMILY WITH SEQUENCE SIMILARITY 58, MEMBER A                                       0.89    0.46    0.47
  SRV_02972_at                                GLUTAREDOXIN 5 HOMOLOG (S. CEREVISIAE)                                             0.97    0.49    0.49
  SRV_05356_at                                FAMILY WITH SEQUENCE SIMILARITY 58, MEMBER A                                       1.09    0.58    0.58
  SRV_05263_at                                SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 3                              0.73    0.45    0.51
  SRV_04739_a\_at                             ZINC FINGER PROTEIN 403                                                            0.97    0.49    0.51
  SRV_03830_at                                SHWACHMAN-BODIAN-DIAMOND SYNDROME                                                  0.94    0.47    0.46
  SRV_03448_at                                COILED-COIL DOMAIN CONTAINING 59                                                   0.89    0.42    0.44
  SRV_02223_a\_at                             ISOPENTENYL-DIPHOSPHATE DELTA ISOMERASE 1                                          0.89    0.37    0.43
  SRV_04160_at                                SDA1 DOMAIN CONTAINING 1                                                           0.88    0.48    0.42
  SRV_05216_at                                SERUM AMYLOID A-LIKE 1                                                             0.82    0.42    0.42
  SRV_04991_a\_at                             MYC INDUCED NUCLEAR ANTIGEN                                                        0.90    0.41    0.39
  SRV_00134_a\_at                             ARGININOSUCCINATE LYASE                                                            1.10    0.44    0.36
  SRV_05376_at                                WILLIAMS BEUREN SYNDROME CHROMOSOME REGION 27                                      0.84    0.36    0.31

###### 

Significant (p ≤ 0.05 geometric mean p-value) functional groups obtained from functional annotation using DAVID.

                       Ontology                      Number of Genes   p-value                        Ontology                                     Number of Genes   p-value
  -------------------- ----------------------------- ----------------- --------- -------------------- -------------------------------------------- ----------------- ---------
  Functional Group 1   response to biotic stimulus   25                \<0.001   Functional Group 5   water-soluble vitamin metabolism             4                 0.02
  \<0.001              immune response               21                \<0.001   0.033                vitamin metabolism                           4                 0.03
                       defense response              22                \<0.001                        pyridine nucleotide metabolism               3                 0.07
                                                                                                                                                                     
  Functional Group 2   cation binding                34                0.001     Functional Group 6   di-, tri-valent inorganic cation transport   5                 0.006
  0.002                ion binding                   36                0.004     0.042                metal ion transport                          5                 0.06
                       metal ion binding             36                0.004                          cation transport                             6                 0.22
                                                                                                                                                                     
  Functional Group 3   innate immunity               4                 0.001     Functional Group 7   bcr protein                                  3                 0.02
  0.005                immune response               5                 0.004     0.045                molecular chaperone                          4                 0.02
                       innate immune response        4                 0.007                          Heat shock protein Hsp70                     3                 0.03
                       complement activation         3                 0.02                           Heat shock protein 70                        3                 0.03
                                                                                                      antigen processing and presentation          4                 0.09
                                                                                                      cell surface                                 3                 0.20
                                                                                                                                                                     
  Functional Group 4   lysosome                      7                 0.002                                                                                         
  0.008                lysosome                      7                 0.009     Functional Group 8   response to unfolded protein                 5                 0.02
                       lytic vacuole                 7                 0.009     0.048                response to protein stimulus                 5                 0.02
                       vacuole                       7                 0.02                           chaperone                                    6                 0.26

![**Expression profiles for cluster 1.** Each row represents an individual gene, and each column a post-infection time point. Red coloration indicates increased expression of a gene relative to uninfected animals, and green indicates decreased expression. Genes (Cluster 1, n = 158) identified to be significantly up-regulated in response to ATV infection.](1471-2164-9-493-2){#F2}

![**Expression profiles for cluster 2.** Each row represents an individual gene, and each column a post-infection time point. Red coloration indicates increased expression of a gene relative to uninfected animals, and green indicates decreased expression. Genes (Cluster 2, n = 105) identified to be significantly down-regulated in response to ATV infection.](1471-2164-9-493-3){#F3}

Genes Up-regulated in Response to ATV
-------------------------------------

Across all time points, the majority of up-regulated genes were related to immune response or other related functions, such as inflammation and apoptosis. Other up-regulated genes pertained to gene functions such as ion binding and transport, membrane related functions, and protein binding and modification. Twenty-three genes (represented by 26 probe sets) demonstrated 2-fold or greater changes at 24 hours post-infection, all of which were up-regulated. Ten of these 23 have functions pertaining to immune response. Of the remaining highly expressed genes, one was associated with inflammation, two to regulation of apoptosis, three to ion binding, three to protein binding and modification, one to transport, one to the extracellular constituent, and one to membrane and glycolipids. Many of these genes showed increasing transcript abundances over time. At 72 hours post infection, 43 genes had a greater than 5-fold change, and 40 genes had a greater than 5-fold change at 144 hours. The highest expression level, 91-fold increase at 144 hours, was observed for *interferon-induced protein with tetracopeptide repeats 5*(IFIT5).

Genes Down-regulated in Response to ATV
---------------------------------------

In contrast to the very high fold changes observed among up-regulated genes, the largest fold change observed among down-regulated genes was approximately 4.9-fold, in *chondroitin sulfate proteoglycan*(NCAN). Five down-regulated genes each code for regulation of transcription and translation. An additional 15 down-regulated genes correspond to 20 probe sets that have functions associated with cell division and mitosis, which was not observed in the up-regulated genes. Other notable down-regulated gene ontologies include one gene corresponding to pinocytosis and endocytosis, and one gene related to natural killer cell mediated cytotoxicity.

Validation of Microarray Results Using Quantitative Real-time PCR
-----------------------------------------------------------------

We used qPCR to estimate fold changes for nine genes to verify our microarray data (Table [4](#T4){ref-type="table"}). For five of the nine genes investigated (56%; *Myxovirus resistance 1, Macrophage receptor with collagenous structure, Complement component 3, Cyclin dependant kinase inhibitor 1B, Vaccinia related kinase 1*) there is good agreement between the microarray and qPCR data. In genes where the microarray estimates of fold change were modest (*Serine dehydratase like, Hemoglobin gamma alpha, Glycogen synthase kinase, Programmed cell death 8*) there is poorer agreement between fold change estimates from these two technologies. However, for this latter group of genes with modest fold change values, the microarray and qPCR data were always within four fold of each other. These results demonstrate that we were able to verify robust differences that were suggested by the microarray data.

###### 

Fold changes obtained from microarray and from quantitative real-time PCR.

  Gene name                                                      Microarray   qPCR    
  ------------------------------------------------------ ------- ------------ ------- -------
                                                         24      72           24      72
                                                                                      
  Myxovirus resistance 1 MX1                             3.13    29.23        5.97    24.44
  Macrophage receptor with collagenous structure MARCO   2.17    8.20         3.36    15.24
  Complement component 3 C3                              1.80    9.79         2.14    14.78
  Cyclin dependant kinase inhibitor 1B CDKN1B            -1.17   -1.74        -2.26   -3.16
  Vaccinia related kinase 1 VRK1                         -1.64   -2.58        -1.23   -1.88
  Serine dehydratase like SDSL                           1.03    -1.92        -1.35   -1.01
  Hemoglobin gamma alpha HBG1                            -1.01   -1.02        -1.54   -1.87
  Glycogen synthase kinase GSK3A                         -1.07   -1.08        -1.13   2.76
  Programmed cell death 8 PDCD8                          1.13    -1.10        1.30    1.85

Analyses to identify proliferation gene expression signatures
-------------------------------------------------------------

Comparison of gene expression after ATV and tail amputation identified 25 genes that are significantly up-regulated in both experimental frameworks (Table [5](#T5){ref-type="table"}). No significantly down-regulated genes were identified in common. Several of the commonly up-regulated genes appear to be related to humoral immunity, and membrane and extracellular matrix related functions. Additionally, general stress response genes such as *heat shock 70 kDa protein 5*were similarly regulated. None of the cell cycle genes that are significantly up-regulated during tail regeneration were identified in this study. Thus, there was no evidence of cell proliferation by spleen cells after ATV infection.

###### 

Genes expressed in both ATV infection and spinal cord injury

  Gene ID           Gene Name                                                                                          Gene Ontology
  ----------------- -------------------------------------------------------------------------------------------------- --------------------------------------------------------------------
  SRV_00294_s\_at   protective protein for beta-galactosidase (galactosialidosis)                                      proteolysis, protein transport
  SRV_00309_at      transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase)   membrane, cell envelope, protein modification
  SRV_00327_a\_at   cathepsin K (pycnodysostosis)                                                                      proteolysis
  SRV_00330_at      cytochrome b-245, beta polypeptide (chronic granulomatous disease)                                 humoral response, inflammatory response
  SRV_00371_a\_at   fructose-1,6-bisphosphatase 1                                                                      metal ion binding (zinc)
  SRV_00442_at      solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1                immune response, ion transport
  SRV_00713_a\_at   transcobalamin I (vitamin B12 binding protein, R binder family)                                    ion transport/binding (cobalt)
  SRV_00744_a\_at   adipose differentiation-related protein                                                            fatty acid transport, extracellular region
  SRV_01179_a\_at   CD63 antigen (melanoma 1 antigen)                                                                  endosome, membrane
  SRV_01342_at      interferon regulatory factor 1                                                                     immune response, transcription
  SRV_01351_at      jun B proto-oncogene                                                                               transcription
  SRV_01818_at      thioredoxin                                                                                        signal transduction
  SRV_02399_a\_at   matrix metalloproteinase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase)           extracellular matrix, apoptosis, proteolysis
  SRV_02456_at      gastric intrinsic factor (vitamin B synthesis)                                                     ion transport/binding (cobalt)
  SRV_02516_at      heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa)                                    anti-apoptosis, endoplasmic reticulum
  SRV_02586_at      lectin, galactoside-binding, soluble, 3 binding protein                                            cell adhesion, cellular defense response, signal transduction
  SRV_03054_at      macrophage receptor with collagenous structure                                                     signal transduction
  SRV_04604_at      interferon induced with helicase c domain 1                                                        innate immune response, regulation of apoptosis, response to virus
  SRV_04819_a\_at   transmembrane protein 49                                                                           membrane, endoplasmic reticulum
  SRV_04888_a\_at   UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5                                      membrane, CNS development
  SRV_04911_at      thioredoxin domain containing 2 (spermatozoa)                                                      cell redox homeostasis
  SRV_04964_a\_at   tubulin beta MGC4083                                                                               nucleotide binding, protein polymerization
  SRV_07726_a\_at   macrophage expressed gene 1                                                                        none
  SRV_11417_a\_at   matrix metalloproteinase 1 (interstitial collagenase)                                              proteolysis, ion binding (zinc)
  SRV_11663_a\_at   tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor)   enzyme inhibitor, cell proliferation
  SRV_00294_s\_at   protective protein for beta-galactosidase (galactosialidosis)                                      proteolysis, protein transport

Discussion and conclusion
=========================

Emerging infectious diseases are implicated in the global decline of amphibians and other animals \[[@B3],[@B49]-[@B51]\]. There is urgent need to develop understanding of amphibian immunological responses to pathogens and to identify host genes that may be important in disease resistance. Our study shows that functional genomics provides a means to rapidly meet these needs. We infected Mexican axolotls from the Ambystoma Genetic Stock Center with a viral pathogen that is clearly affecting tiger salamander populations in nature \[[@B10],[@B13]-[@B15],[@B19]\]. Our results show that ATV infection induces transcriptional changes of genes that are known to function in vertebrate immunity. Below we discuss the transcriptional response in more detail and suggest hypotheses to explain why ATV is often lethal to axolotls and other tiger salamanders.

We detected significant gene expression changes 24 hours post infection. Many of these gene expression changes likely reflect transcription within lymphocytes, as they are the predominant cell type in the spleen of juvenile and adult axolotls \[[@B52]\]. Indeed, the functions of many of these genes are associated with neutrophil, dendritic, and macrophage cell functions, including cytokine signaling (*chemokine (C-X-C motif) receptor 4*), phagocytosis and destruction of phagocytised particles (*disabled homolog 2, mitogen-responsive phosphoprotein, neutrophil cytosolic factor 2*, *lysosomal-associated membrane protein 1*, *RAS homolog gene family, member B*), complement (*complement factor B*, *complement component 3*), and inflammation (*pentraxin related gene, rapidly induced by IL-1 beta*, *cytochrome B-245 beta polypeptide*, *n-myc and STAT interactor*). Up-regulation of complement components that are known to function in the removal of viral particles, and up-regulation of the stress-associated transcription factor *jun-b*, clearly shows that ATV induced a humoral gene expression response in the axolotl. Further support for this idea was obtained by comparing ATV-induced gene expression changes to changes identified from a previous microarray experiment using *A. mexicanum*and the same microarray platform. Twenty-five genes that were up-regulated in response to ATV infection were also identified as significantly up-regulated during regeneration \[[@B31]\]. In both microarray studies, blood was not perfused from tissues prior to tissue collection and it is known that leukocyctes express genes during the early wound-healing phase of spinal cord and limb regeneration. Thus, it seems likely that many of the early gene expression changes that we observed in response to ATV-infection reflect a general, humoral transcriptional response to stress.

In addition to this general humoral response, **t**he gene expression patterns that we observed suggest that the Mexican axolotl manifests an antiviral transcriptional response that is not unlike that observed in other vertebrates. For example, ATV infection clearly induces an interferon-mediated, antiviral response. Although probe sets for interferon genes are not represented on the GeneChip, we estimate based upon literature surveys that at least 20% of the significant genes that we identified are known in other systems (*in vitro*and *in vivo*) to be involved in interferon-mediated transcription \[[@B53]-[@B55]\]. These genes exhibited some of the largest fold-changes and include two primary transcription factors that compete to activate (*interferon regulatory factor 1*, up-regulated) and repress (*interferon regulatory factor 2*, down-regulated) transcription of interferon-alpha and beta (Type 1 interferon), and inferon-inducible genes that recognize and degrade intra-cellular viral nucleic acid (*interferon induced with helicase C domain 1*). Considering further that four of the most highly enriched functional groups also contained genes relating to the immune response and pathogen response, the results show that axolotls mount a robust anti-viral response from 24--144 hours post-infection.

Given the robust immunological transcription response that we observed, it is curious why ATV is so virulent to tiger salamanders. In the closely related *Ranavirus*frog virus 3 (FV3), larval *Xenopus laevis*succomb to FV3 but adults effectively clear virons and develop lasting resistance to future infection \[[@B56]\]. Adult resistance in *X. laevis*is correlated with a significant proliferation of cytotoxic CD8^+^T cells in the spleen upon infection (within 6 days), as well as increased mortality upon CD8^+^T cell depletion \[[@B30],[@B57]\]. Mortality events due to ATV are more significant among larvae in natural tiger salamander populations, however metamorphosed adult tiger salamanders are more susceptible than larvae to ATV infection in the lab \[[@B18]\]. It is well established that Mexican axolotls have a less complicated immune system and never develop the type of mature immune response typical of amniote vertebrates \[[@B21]-[@B29],[@B52]\]. We did not observe any gene expression changes that would indicate proliferative leukocyte responses in axolotl spleen. Perhaps this is because we used juvenile axolotls that are incapable of such a response. However, it is also possible that ATV maybe more resistant to the immune response mounted by *A. mexicanum*than FV3 is to the *Xenopus*immune response. Phylogenetic analyses indicate ATV is more closely related to iridoviruses found in fish than to FV3, which suggests a relatively recent host switch occurring with the introduction of sportfish to areas of the southwestern United States \[[@B15]\]. Iridoviruses found in sportfish have a larger genome and contain more ORFs related to immune evasion than FV3, which could also be related to improved performance of this virus on the salamander host \[[@B15]\]. Further studies are needed to better understand the ontogeny of immunological responses in axolotls, the virulence of different ranaviruses, and the role of innate versus adaptive immunity in ATV infection.

Our study has identified hundreds of new candidate genes for laboratory and field studies of stress and disease in tiger salamanders. Significantly more gene candidates will undoubtedly be discovered using a higher content, 2^nd^generation microarray that is currently under development. Genomic and bioinformatics tools make *Ambystoma*a powerful system for wildlife disease research. In particular, molecular information can be quickly cross-referenced from a genetically homogeneous strain that is available for laboratory studies (Mexican axolotl), to other closely related tiger salamander species in North America \[[@B20]\]. Such power is needed to quickly understand how ATV and other pathogens are overwhelming amphibian immune responses and causing population declines in nature.
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